No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects

By Yao Lei  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 237-242

Springer Publishing Company

Access to resources Recommend Favorite

A Family-based Genetic Association Study of Variants in Estrogen-metabolism Genes COMT and CYP1B1 and Breast Cancer Risk

By Ahsan Habibul   Chen Yu   Whittemore Alice   Kibriya Muhammad   Gurvich Irina   Senie Ruby   Santella Regina  

Breast Cancer Research and Treatment, Vol. 85, Iss. 2, 2004-05 ,pp. : 121-131

Springer Publishing Company

Access to resources Recommend Favorite

Association of genetic polymorphisms in CYP19 and CYP1A1 with the oestrogen receptor-positive breast cancer risk

By Miyoshi Y.   Ando A.   Hasegawa S.   Ishitobi M.   Yamamura J.   Irahara N.   Tanji Y.   Taguchi T.   Tamaki Y.   Noguchi S.  

European Journal of Cancer, Vol. 39, Iss. 17, 2003-11 ,pp. : 2531-2537

Elsevier

Access to resources Recommend Favorite

Can the Status of the Breast and Ovarian Cancer Susceptibility Gene 1 Product (BRCA1) Predict Response to Taxane-Based Cancer Therapy?

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 5, 2009-06 ,pp. : 543-549

Bentham Science Publishers

Access to resources Recommend Favorite

Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent meta-analysis

By Economopoulos Konstantinos  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 293-294

Springer Publishing Company

Access to resources Recommend Favorite